Atorvastatin increases lipopolysaccharide‑induced expression of tumour necrosis factor‑α‑induced protein 8‑like 2 in RAW264.7 cells

Liu,Ming‑wei; Su,Mei‑xian; Zhang,Wei; Wang,Li; Qian,Chuan‑yun

doi:10.3892/etm.2014.1722

Atorvastatin increases lipopolysaccharide‑induced expression of tumour necrosis factor‑α‑induced protein 8‑like 2 in RAW264.7 cells

Authors:
- Ming‑wei Liu
- Mei‑xian Su
- Wei Zhang
- Li Wang
- Chuan‑yun Qian
View Affiliations

Affiliations: Department of Emergency, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China, Surgica Intensive Care Unit, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650106, P.R. China
Published online on: May 19, 2014 https://doi.org/10.3892/etm.2014.1722
Pages: 219-228

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

RAW264.7 cells are one of the major sources of productive inflammatory biomediators, including tumour necrosis factor‑α (TNF‑α) and interleukin (IL)‑6. TNF‑α‑induced protein 8‑like 2 (TIPE2) is an essential negative regulator of Toll‑like and T‑cell receptors, and the selective expression in the immune system prevents hyper‑responsiveness and maintains immune homeostasis. The aim of the present study was to investigate whether atorvastatin upregulates the expression of TIPE2 and further regulates the inflammatory response and oxidation emergency response in RAW264.7 cells. RAW264.7 cells were incubated in Dulbecco's modified Eagle's medium containing lipopolysaccharide (LPS) in the presence or absence of atorvastatin. Following incubation, the medium was collected and the levels of TNF‑α and IL‑6 were measured using an enzyme‑linked immunosorbent assay. The cells were harvested, and the mRNA and protein expression levels of TIPE2, macrophage migration inhibitory factor (MIF), IκB and nuclear factor (NF‑κB)‑κB were analysed using quantitative polymerase chain reaction and western blotting analysis, respectively, the expression of NOS, COX-2 and HO-1 protein were essayed by western blotting analysis, NO and ROS activities were determined. The results revealed that LPS increased the mRNA and protein expression levels of TIPE2, MIF and NF‑κB, as well as the production of IL-6 and TNF‑α, in a dose and time dependent manner in RAW264.7 cells. Meanwhile, LPS enhanced the expression of NOS and COX-2 protein, blocked HO-1 protein expression, increased NO and PGE2 production and ROS activity in a dose dependent manner in RAW264.7 cells. Atorvastatin significantly increased LPS induced expression of TIPE2, downregulated the expression of NOS, COX-2, MIF and NF‑κB and the production of PGE2, NO, IL-6 and TNF‑α in a time and dose dependent manner, and increased HO-1 protein expression, reduced ROS production in a dose dependent manner. The observations indicated that atorvastatin upregulated LPS induced expression of TIPE2 and consequently inhibited MIF, NF‑κB, NOS and COX-2 expression and the production of NO, PGE2, TNF‑α and IL‑6, increased HO-1 expression, and inhibited ROS activity in cultured RAW264.7 cells.

View Figures

View References

1	Wynn J, Cornell TT, Wong HR, Shanley TP and Wheeler DS: The host response to sepsis and developmental impact. Pediatrics. 125:1031–1041. 2010. View Article : Google Scholar : PubMed/NCBI
2	Unuma K, Aki T, Funakoshi T, Yoshida K and Uemura K: Cobalt protoporphyrin accelerates TFEB activation and lysosome reformation during LPS-induced septic insults in the rat heart. PLoS One. 8:e565262013. View Article : Google Scholar : PubMed/NCBI
3	Juskewitch JE, Prasad S, Salas CF and Huskins WC: Reliability of the identification of the systemic inflammatory response syndrome in critically ill infants and children. Pediatr Crit Care Med. 13:e55–e57. 2012. View Article : Google Scholar : PubMed/NCBI
4	Walley KR, Lukacs NW, Standiford TJ, Strieter RM and Kunkel SL: Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun. 64:4733–4738. 1996.PubMed/NCBI
5	Cinel I and Opal SM: Molecular biology of inflammation and sepsis: a primer. Crit Care Med. 37:291–304. 2009. View Article : Google Scholar : PubMed/NCBI
6	Woodward MJ, de Boer J, Heidorn S, Hubank M, Kioussis D, Williams O and Brady HJ: TNFAIP8 is an essential gene for the regulation of glucocorticoid-mediated apoptosis of thymocytes. Cell Death Differ. 17:316–323. 2010. View Article : Google Scholar : PubMed/NCBI
7	Wang Z, Fayngerts S, Wang P, et al: TIPE2 protein serves as a negative regulator of phagocytosis and oxidative burst during infection. Proc Natl Acad Sci USA. 109:15413–15418. 2012. View Article : Google Scholar : PubMed/NCBI
8	Freundt EC, Bidere N and Lenardo MJ: A different TIPE of immune homeostasis. Cell. 133:401–402. 2008. View Article : Google Scholar : PubMed/NCBI
9	Antonopoulos AS, Margaritis M, Lee R, Channon K and Antoniades C: Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des. 18:1519–1530. 2012. View Article : Google Scholar : PubMed/NCBI
10	Truwit JD: Statins: a role in infected critically ill patients? Crit Care. 15:1452011. View Article : Google Scholar : PubMed/NCBI
11	Rubinson DA, Dillon CP, Kwiatkowski AV, et al: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 33:401–406. 2003. View Article : Google Scholar : PubMed/NCBI
12	Wu L, Gokden N and Mayeux PR: Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol. 18:1807–1815. 2007. View Article : Google Scholar : PubMed/NCBI
13	Dombrovskiy VY, Martin AA, Sunderram J and Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 35:1244–1250. 2007. View Article : Google Scholar : PubMed/NCBI
14	Vigil KJ, Adachi JA and Chemaly RF: Viral pneumonias in immunocompromised adult hosts. J Intensive Care Med. 25:307–326. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hlava N, Niemann CU, Gropper MA and Melcher ML: Postoperative infectious complications of abdominal solid organ transplantation. J Intensive Care Med. 24:3–17. 2009. View Article : Google Scholar : PubMed/NCBI
16	Zhao J, Yang X, Auh SL, Kim KD, Tang H and Fu YX: Do adaptive immune cells suppress or activate innate immunity? Trends Immunol. 30:8–12. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H and Fu YX: Adaptive immune cells temper initial innate responses. Nat Med. 13:1248–1252. 2007. View Article : Google Scholar : PubMed/NCBI
18	López-Rincón G, Pereira-Suárez AL, Del Toro-Arreola S, et al: Lipopolysaccharide induces the expression of an autocrine prolactin loop enhancing inflammatory response in monocytes. J Inflamm (Lond). 10:242013.PubMed/NCBI
19	Jeong IK, Oh da H, Park SJ, et al: Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Exp Mol Med. 43:684–692. 2011.
20	Lin CC, Shih CH, Yang YL, et al: Thrombin induces inducible nitric oxide synthase expression via the MAPK, MSK1, and NF-κB signaling pathways in alveolar macrophages. Eur J Pharmacol. 672:180–187. 2011.PubMed/NCBI
21	Zhang LJ, Liu X, Gafken PR, Kioussi C and Leid M: A chicken ovalbumin upstream promoter transcription factor I (COUP-TFI) complex represses expression of the gene encoding tumor necrosis factor alpha-induced protein 8 (TNFAIP8). J Biol Chem. 284:6156–6168. 2009. View Article : Google Scholar
22	Sun H, Gong S, Carmody RJ, et al: TIPE2, a novel negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 133:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
23	Laliberté B, Wilson AM, Nafisi H, et al: TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation. J Cell Physiol. 225:865–874. 2010.PubMed/NCBI
24	Antosz H and Choroszyńska D: Negative regulation of Toll-like receptor signalling. Postepy Hig Med Dosw (Online). 67:339–350. 2013.(In Polish).
25	Zhang X, Wang J, Fan C, et al: Crystal structure of TIPE2 provides insights into immune homeostasis. Nat Struct Mol Biol. 16:89–90. 2009. View Article : Google Scholar : PubMed/NCBI
26	Li D, Song L, Fan Y, et al: Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol. 133:422–427. 2009. View Article : Google Scholar : PubMed/NCBI
27	Zhang Y, Zeng X, Chen S, et al: Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor. Int Immunopharmacol. 11:1333–1340. 2011. View Article : Google Scholar
28	Healy ZR, Liu H, Holtzclaw WD and Talalay P: Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory intervention. Cancer Epidemiol Biomarkers Prev. 20:1516–1523. 2011. View Article : Google Scholar : PubMed/NCBI
29	Donnelly LE and Rogers DF: Novel targets and drugs in inflammatory lung disease. Curr Opin Pharmacol. 8:219–221. 2008. View Article : Google Scholar : PubMed/NCBI
30	Tu YP, Chuang SJ, Chen SC, et al: Simvastatin induces the expression of hemeoxygenase-1 against ischemia-reperfusion injury on the testes in rats. Toxicol Lett. 207:242–250. 2011. View Article : Google Scholar : PubMed/NCBI
31	Park JS, Jung JS, Jeong YH, et al: Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: critical role of heme oxygenase-1 and NQO1 expression. J Neurochem. 119:909–919. 2011. View Article : Google Scholar : PubMed/NCBI
32	Nassar NN, Li G, Strat AL and Abdel-Rahman AA: Enhanced hemeoxygenase activity in the rostral ventrolateral medulla mediates exaggerated hemin-evoked hypotension in the spontaneously hypertensive rat. J Pharmacol Exp Ther. 339:267–274. 2011. View Article : Google Scholar
33	Kagami S, Kanari H, Suto A, et al: HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells. Int Arch Allergy Immunol. 146(Suppl 1): 61–66. 2008. View Article : Google Scholar : PubMed/NCBI
34	Trezzi M, Blackstone EH, Sun ZY, et al: Statin therapy is associated with fewer infections after cardiac operations. Ann Thorac Surg. 95:892–900. 2013. View Article : Google Scholar : PubMed/NCBI
35	Chello M, Anselmi A, Spadaccio C, et al: Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg. 83:1374–1380. 2007. View Article : Google Scholar : PubMed/NCBI
36	Chello M, Mastroroberto P, Patti G, D’Ambrosio A, Morichetti MC, Di Sciascio G and Covino E: Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart. 89:538–543. 2003. View Article : Google Scholar
37	Chaudhry MZ, Wang JH, Blankson S and Redmond HP: Statin (cerivastatin) protects mice against sepsis related death via reduced proinflammatory cytokines and enhanced bacterial clearance. Surg Infect (Larchmt). 9:183–194. 2008. View Article : Google Scholar
38	Fraunberger P, Gröne E, Gröne HJ and Walli AK: Simvastatin reduces endotoxin induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low density lipoprotein cholesterol. Shock. 32:159–163. 2009. View Article : Google Scholar
39	Lin H, Xiao Y, Chen G, et al: HMG CoA reductase inhibitor simvastatin suppresses Toll like receptor 2 ligand induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients. Rheumatol Int. 31:1451–1458. 2011. View Article : Google Scholar
40	Meijvis SC, van de Garde EM, Rijkers GT and Bos WJ: Treatment with anti inflammatory drugs in community acquired pneumonia. J Intern Med. 272:25–35. 2012. View Article : Google Scholar : PubMed/NCBI
41	Fogerty MD, Efron D, Morandi A, Guy JS, Abumrad NN and Barbul A: Effect of preinjury statin use on mortality and septic shock in elderly burn patients. J Trauma. 69:99–103. 2010. View Article : Google Scholar : PubMed/NCBI
42	González CM, Luna AH, Morales MP, Sanchez JA, Guzman CO and Granillo GF: Statin anti-inflammatory therapy in septic patients. Critical Care. 12(Suppl5): P26–P35. 2008.